ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "osteoarthritis and self-management"

  • Abstract Number: 2006 • 2014 ACR/ARHP Annual Meeting

    Multiple Joint Osteoarthritis: Patient Preferences for a Generic Exercise and Self-Management Programme

    Nicola E. Walsh1, Geeta Patel2 and Rachael Gooberman-Hill3, 1Allied Health Professions, University of the West of England Bristol, Bristol, United Kingdom, 2Allied Health Professions, University of the West of England, Bristol, Bristol, United Kingdom, 3Orthopaedics, University of Bristol, Bristol, United Kingdom

    Background/Purpose: In the UK approximately 1.75 million people age 45 and over are diagnosed with multiple, peripheral joint osteoarthritis (OA), a figure that would increase significantly with…
  • Abstract Number: 2842 • 2013 ACR/ARHP Annual Meeting

    Cochrane Systematic Review Of Self-Management Education Programs For People With Osteoarthritis

    Féline P.B. Kroon1, Lennart R.A. van der Burg1, Rachelle Buchbinder2, Richard H. Osborne3 and Veronica Pitt4, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Monash Department of Clinical Epidemiology at Cabrini Hospital, Department of Epidemiology and Preventive Medicine, Monash University, Malvern, Victoria, Australia, 3Public Health Innovation, Deakin University, Melbourne, Australia, 4National Trauma Research Institute, The Alfred Hospital, Monash University, Melbourne, Australia

    Background/Purpose: We performed a Cochrane systematic review to determine the effectiveness of self-management education programs (SMPs) for people with osteoarthritis (OA). Methods: Published randomised controlled…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology